Merrimack Pharmaceuticals Inc (MACK)
14.71
-0.02
(-0.14%)
USD |
NASDAQ |
Apr 24, 16:00
14.73
+0.02
(+0.14%)
Pre-Market: 20:00
Merrimack Pharmaceuticals Total Liabilities (Quarterly): 0.441M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.441M |
| September 30, 2023 | 0.493M |
| June 30, 2023 | 0.411M |
| March 31, 2023 | 0.463M |
| December 31, 2022 | 0.589M |
| September 30, 2022 | 0.448M |
| June 30, 2022 | 0.441M |
| March 31, 2022 | 0.564M |
| December 31, 2021 | 0.562M |
| September 30, 2021 | 0.683M |
| June 30, 2021 | 0.772M |
| March 31, 2021 | 0.684M |
| December 31, 2020 | 0.77M |
| September 30, 2020 | 2.218M |
| June 30, 2020 | 2.335M |
| March 31, 2020 | 3.296M |
| December 31, 2019 | 2.77M |
| September 30, 2019 | 4.739M |
| June 30, 2019 | 4.996M |
| March 31, 2019 | 25.39M |
| December 31, 2018 | 29.72M |
| September 30, 2018 | 36.87M |
| June 30, 2018 | 17.95M |
| March 31, 2018 | 18.24M |
| December 31, 2017 | 21.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 86.21M |
| June 30, 2017 | 106.94M |
| March 31, 2017 | 344.38M |
| December 31, 2016 | 334.14M |
| September 30, 2016 | 345.19M |
| June 30, 2016 | 351.58M |
| March 31, 2016 | 410.13M |
| December 31, 2015 | 418.57M |
| September 30, 2015 | 243.83M |
| June 30, 2015 | 248.38M |
| March 31, 2015 | 256.24M |
| December 31, 2014 | 260.58M |
| September 30, 2014 | 288.32M |
| June 30, 2014 | 206.92M |
| March 31, 2014 | 230.95M |
| December 31, 2013 | 235.54M |
| September 30, 2013 | 240.50M |
| June 30, 2013 | 165.42M |
| March 31, 2013 | 159.39M |
| December 31, 2012 | 155.39M |
| September 30, 2012 | 110.19M |
| June 30, 2012 | 105.62M |
| March 31, 2012 | 376.28M |
| December 31, 2011 | 106.99M |
| September 30, 2011 | 363.28M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.411M
Minimum
Jun 2023
4.996M
Maximum
Jun 2019
1.457M
Average
0.683M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.19M |
| Shareholders Equity (Quarterly) | 18.75M |